For patients with rheumatoid arthritis (RA), those choosing their own treatment have higher treatment satisfaction, better treatment retention and fewer reported adverse events, according to a study published online Oct. 27 in RMD Open.
A study led by the Cell Cycle and Cancer Group at the Vall d'Hebron Institute of Oncology (VHIO) has identified a vulnerability in liver cancer that could guide the development of new therapies.
Researchers have developed a new approach that uses synthetic DNA molecules to target cancer-linked genes directly, opening new possibilities for future treatments, diagnostics and biological…
Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr.